'Clinical Trials' Archive | RSS

Suberoylanilide Hydroxamic Acid (SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma 

Suberoylanilide Hydroxamic Acid (SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma
This study is currently recruiting patients.Verified by Merck April 2007

Sponsored by:
Merck

Information provided by:
Merck

ClinicalTrials.gov Identifier:
NCT00128102

Purpose

This is […]

Trial of Cisplatin, Imatinib Mesylate, and Pemetrexed in Malignant Mesothelioma Patients 

This study is currently recruiting patients.
Verified by M.D. Anderson Cancer Center November 2006

Sponsors and Collaborators:
M.D. Anderson Cancer Center
Novartis

Information provided by:
M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier:
NCT00402766

Purpose
Primary Objective:1. To determine the maximum tolerated dose of the combination of […]

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma 

This study is currently recruiting patients.
Verified by Dana-Farber Cancer Institute January 2007

Sponsors and Collaborators:
Dana-Farber Cancer Institute
Massachusetts General Hospital
University of Chicago

Information provided by:
Dana-Farber Cancer Institute

ClinicalTrials.gov Identifier:
NCT00137826

Purpose
The purpose of this study is to determine whether the combination of […]

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung 

This study is currently recruiting patients.
Verified by National Cancer Institute (NCI) November 2006

Sponsors and Collaborators:
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)

Information provided by:
National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:
NCT00398138

Purpose

RATIONALE: Vaccines made from peptides may help the body […]

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma 

This study is currently recruiting patients.
Verified by National Cancer Institute (NCI) September 2006

Sponsored by:
Burzynski Research Institute

Information provided by:
National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:
NCT00003508

Purpose
RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may […]

Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma 

This study is currently recruiting patients.
Verified by National Cancer Institute (NCI) August 2006

Sponsors and Collaborators:
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Information provided by:
National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:
NCT00354393

Purpose
RATIONALE: Drugs used in chemotherapy, such as methotrexate, vinorelbine, and cisplatin, work in different ways to […]

Pemetrexed Disodium and Either Gemcitabine or Carboplatin in Treating Patients With Advanced Malignant Pleural Mesothelioma 

This study is currently recruiting patients.
Verified by National Cancer Institute (NCI) July 2006

Sponsors and Collaborators:
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
North Central Cancer Treatment Group

Information provided by:
National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:
NCT00101283

Purpose

RATIONALE: Drugs used in chemotherapy, […]

A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer 

This study is currently recruiting patients.
Verified by Morphotek July 2006

Sponsored by:
Morphotek

Information provided by:
Morphotek

ClinicalTrials.gov Identifier:
NCT00325494

Purpose
The purpose of this study is to establish the safest doses of an investigational drug called MORAb-009 in subjects with pancreatic cancer, mesothelioma, or certain types […]